International
The Morning Science

What science found today

‹
 

Research

Associations of anti-carbamylated protein antibodies with systemic inflammation and osteoporosis in rheumatoid arthritis: a cross-sectional study

Nature ·

The Brief

  • A cross-sectional study examined anti-carbamylated protein (anti-CarP) antibodies in rheumatoid arthritis patients.
  • The study reports associations of these antibodies with systemic inflammation.
  • The study also reports associations of these antibodies with osteoporosis.

Why it matters

Linking anti-CarP antibodies to inflammation and osteoporosis in rheumatoid arthritis could help clinicians and researchers understand bone involvement in the disease. As a cross-sectional study, it shows associations rather than cause and effect.

Who’s affected

  • rheumatologists and clinicians treating rheumatoid arthritis
  • researchers studying autoantibodies, inflammation and bone health

Timeline

  1. Study listed in nature.com subject feed

  2. Medical research : nature.com subject feeds

    Associations of anti-carbamylated protein antibodies with systemic inflammation and osteoporosis in rheumatoid arthritis: a cross-sectional study

How do you feel about this?

0 Comments

    Associations of anti-carbamylated protein antibodies with systemic inflammation and osteoporosis in rheumatoid arthritis: a cross-sectional study – The Morning Science